Onco-Tools, LLC was founded in Philomath, Oregon in 2009 as a research company in pursuit of the development of safe and effective cancer treatments. In late-2016, Onco-Tools co-developed Onco-Morpholinos in collaboration with Gene Tools, LLC. Onco-Morpholinos are high-specificity delivery-enhanced Morpholino oligos targeted against cancer-related RNA transcripts. In August 2017, we launched our website to sell Onco-Morpholinos as reagents to the cancer research community. Onco-Tools continues to invest in research towards the crucial goal of transitioning Morpholino technology from bench to bedside, from cell culture experiments to personalized medicine.